AI summary by TwinMind
Uğur Şahin and Özlem Türeci: Meet the scientist couple driving an mRNA vaccine revolution | TED
TED
24m 54s
Background and Meeting
- Tommy (Uğur Şahin) and Özlem Türeci met on oncology/hematology ward
- Tommy was young physician, Özlem in medical school training
- Met in world of patient care treating oncohematology patients
- Shared dilemma: limited treatment options for cancer patients despite promising lab technologies
- Shared vision: bridge gap by bringing science/technology fast to patient bedside for high medical need
Early Company Formation and Marriage
- First company founded ~20 years ago to use immune system against cancer
- As immunologists, knew power of human immune system but it didn't fight cancer cells naturally
- Wanted to develop immunotherapies to redirect immune system to cancer cells
- University setting inadequate for monoclonal antibody development
- Cost: 20-30 million euros before clinical trials
- Founded company to secure funding
- Wedding: well-planned quick ceremony, returned to laboratory afterward
- Guests were research team members
- "No time to lose" mentality
Work-Life Integration Philosophy
- Don't differentiate between work and life balance
- Consider being scientists a privilege
- Combine normal life with professional life seamlessly
- Love what they do as "true scientists"
mRNA Technology Development
- mRNA: natural molecule, one of first small molecules of life
- Carrier of genetic information, unlike DNA it's not stable
- Can transfer information to human cells to build therapeutic proteins
- Vaccine proteins
- Antibodies
- Other drug proteins
- Key advantage: can be produced within few days
- Fascinated by speed for personalized cancer medicines
- Cancer treatment challenge: every patient has different tumor
- Similarity between two patients' same tumor type: <3%
- 97% is unique to individual patient
- Sought technology for personalized immunotherapy within shortest possible time
- Get genetic sequence of tumor, make personalized vaccine within few weeks
mRNA as Universal Platform
- DNA like library/Oxford English Dictionary (reference)
- mRNA does actual living work (like language in use)
- Platform can deliver any type of message to body cells
- Versatile: can deliver protein blueprints and instructions
- Can design into mRNA:
- What protein to produce
- How protein should be built
- Instructions to protein factories
- Control protein amounts and duration
- Define pharmacokinetics in cells
COVID-19 Vaccine Development Timeline
- End January 2020: read paper about Wuhan outbreak
- Realized features indicated global pandemic potential
- Concerned about life changes and mankind's fate
- Had mRNA technology developed for personalized cancer therapy
- Similar situation: genetic information available (virus sequence released 2 weeks earlier)
- Task: make vaccine as fast as possible
- Challenge: almost nothing known about completely new virus
- Target selection: spike protein on virus surface
- 20-25-30 spike proteins per virus
- Two functions: enables virus to stick to human cells (lung), acts as key for cell entry
- Goal: engineer immune response against spike protein
Vaccine Mechanism and Results
- mRNA nanoparticles encapsulated in lipids
- Delivered specifically to lymph nodes, not just anywhere
- Reaches dendritic cells (immune system coaches/generals)
- Dendritic cells train different special forces on "wanted poster"
- Animal model results: lymph node comparison
- Left side: no RNA treatment
- Right side: RNA vaccination showing many red dots (T cells)
- T cells trained to recognize antigen, expanded to army of clones
- All focused on attacking specific mRNA-encoded protein
Clinical Trial Results
- Sunday when waiting for results from independent committee
- Uncertain whether thumbs up or down
- Relief and joy: vaccine highly efficacious >90%
- Protection against severe infection and fatalities almost complete
- Sunday evening: handful of people knew effective vaccine existed
- Shared information next day
Future Pandemic Preparedness
- Current challenge: insufficient production capacity
- Need for next pandemic: develop AND manufacture/distribute at light speed
- Requirement: idle manufacturing capacity
- Goal: produce 12 billion doses (considering prime-boost) within <6 months
- Technically possible with government/international investment
- Need standardized plan/process for faster response
- Potential: vaccine development and distribution start in <8 months
Cancer and Other Disease Applications
- Now have approved technology and first approved product
- COVID vaccine demonstrates mRNA power and safety
- Opens door for new technology and molecule types
- Current cancer pipeline: >10 products in clinical development
- Diverse against different cancer types
- Confident infectious disease success will continue with cancer immunotherapies
- Revolutionary vs traditional drugs:
- Traditional drugs change chemical environment of body area
- mRNA allows specific, precise interventions
- Potential next revolution in bio-pharma landscape
- Disease as disturbed cell communication
- Example: autoimmune disease (immune cells attacking normal cells)
- Could engineer mRNA therapies to teach immune system to stop specific attacks
- Precise communication with problem cells without inhibiting whole immune system
Company Transformation and Wealth
- Company value rocketed, both now billionaires
- "Too much money never a problem" - innovation requires investment
- Prevents only me-too products or incremental improvements
- Beginning 2020: product candidates in clinical testing but required regular funding
- Now: can address full company vision at larger, broader scale
- Bring innovations faster to patients
- Vision: provide novel treatments wherever high unmet medical need exists
Immigration and Diversity Impact
- Both from families who immigrated from Turkey to Germany
- May have helped transform immigration debate in Germany through success
- Surprised by attention to their background
- Science approach: don't ask where person comes from, but what they can contribute
- Company employees from >60 countries
- International group of scientists like any research institution
- Globalization helps bring scientists/engineers together for extraordinary results
- Consider this normal way excellent research and science works
